EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+2.43%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$1.21B
(-3.2%)
Cap. Flow
-$36.6M
Cap. Flow
% of AUM
-3.03%
Top 10 Holdings %
Top 10 Hldgs %
49.32%
Holding
122
New
19
Increased
31
Reduced
32
Closed
17
Top Buys
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$60.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$27.8M |
| 3 |
Labcorp
LH
|
$26M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$24.5M |
| 5 |
Masimo
MASI
|
$18.1M |
Sector Composition
| 1 | Healthcare | 93.47% |
| 2 | Industrials | 1.55% |
| 3 | Technology | 0.08% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
HCA Healthcare
HCA
$94.5B
| $12.6M | 0.81% | 49,094 +10,728 | +28% | +$2.76M |
|
|
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.1M | 0.78% | 231,787 +1,043 | +0.5% | +$54.6K |
|
28
Alnylam Pharmaceuticals
ALNY
$58.5B
| $11.9M | 0.76% | 70,240 +11,007 | +19% | +$1.87M |
|
29
Ionis Pharmaceuticals
IONS
$6.79B
| $11.7M | 0.75% | 384,789 -65,712 | -15% | -$2M |
|
30
ARK Innovation ETF
ARKK
$7.45B
| $11.3M | 0.72% | 119,118 +84,118 | +240% | +$7.96M |
|
|
NSTG
31
DELISTED
NanoString Technologies, Inc.
NSTG
| $11.2M | 0.72% | 265,695 +97,027 | +58% | +$4.1M |
|
32
Guardant Health
GH
$8.41B
| $10M | 0.64% | 100,334 -27 | -0% | -$2.7K |
|
|
MGLN
33
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.95M | 0.64% | 104,700 | – | – |
|
34
Exelixis
EXEL
$10.1B
| $9.79M | 0.63% | 535,700 +19,393 | +4% | +$355K |
|
35
Natera
NTRA
$23.1B
| $9.53M | 0.61% | 102,071 -10,118 | -9% | -$945K |
|
|
TARO
36
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $9.08M | 0.58% | 181,151 +1,785 | +1% | +$89.4K |
|
37
Qiagen
QGEN
$10.1B
| $9.03M | 0.58% | 162,534 +19,425 | +14% | +$1.08M |
|
|
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
| $8.95M | 0.57% | 550,966 -223,625 | -29% | -$3.63M |
|
|
SYNH
39
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $8.79M | 0.56% | +85,612 | New | +$8.79M |
|
40
iRhythm Technologies
IRTC
$5.46B
| $8.61M | 0.55% | 73,169 -40,685 | -36% | -$4.79M |
|
41
Insulet
PODD
$23.9B
| $8.03M | 0.51% | +30,172 | New | +$8.03M |
|
42
Biogen
BIIB
$19.4B
| $7.93M | 0.51% | +33,041 | New | +$7.93M |
|
43
argenx
ARGX
$43.6B
| $7.53M | 0.48% | 21,496 +15,750 | +274% | +$5.52M |
|
|
CERN
44
DELISTED
Cerner Corp
CERN
| $7.22M | 0.46% | +77,543 | New | +$7.22M |
|
45
Liquidia Corp
LQDA
$2.38B
| $7.05M | 0.45% | 1,447,898 +518,849 | +56% | +$2.53M |
|
46
IQVIA
IQV
$32.4B
| $6.95M | 0.44% | 24,618 +17,828 | +263% | +$5.03M |
|
47
Xenon Pharmaceuticals
XENE
$2.98B
| $6.55M | 0.42% | +209,519 | New | +$6.55M |
|
48
AnaptysBio
ANAB
$569M
| $6.35M | 0.41% | 182,612 +104,558 | +134% | +$3.63M |
|
49
Revvity
RVTY
$10.5B
| $6.21M | 0.4% | 30,869 -16,212 | -34% | -$3.26M |
|
50
SI-BONE Inc
SIBN
$719M
| $5.73M | 0.37% | 258,094 +108,094 | +72% | +$2.4M |
|